Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80
Organisation › Details

Quantro Therapeutics GmbH

QUANTRO Therapeutics (“QUANTRO”) is a research-based entity that strives to discover and develop novel therapeutics interfering with disease-causing transcriptional programs in cancer and other diseases. QUANTRO will assemble a highly innovative drug-discovery pipeline that employs time-resolved RNA sequencing and comparative transcriptomics to identify and develop drug candidates interfering with transcriptional regulators. The first focus will be on cancer-associated transcription factors, which so far have been unamenable to pharmacologic intervention. QUANTRO was founded as a spin-off of the Institute of Molecular Biotechnology (“IMBA”) and the Research Institute of Molecular Pathology (“IMP”), both located in Vienna, Austria. Seed investors are Boehringer Ingelheim Venture Fund and Evotec. *


Period Start 2020-07-21 established (s-offc
  Predecessor IMBA – Institute of Molecular Biotechnology GmbH
Products Industry BIOTECH
  Industry 2 Transcriptional Fingerprinting technology
Persons Person Nachtigall, Dieter (Quantro Therapeutics 202007 CEO before Boehringer Ingelheim)
  Person 2 Ameres, Stefan (IMBA 2012– Group Lead + Quantro Therapeutics 202007 Co-Founder + Scientific Adivsor)
Region Region Wien (Vienna)
  Country Austria
  Street 7 Dr. Bohr-Gasse
Vienna BioCenter
  City 1030 Wien
  Tel +32-664-9158-111
    Address record changed: 2020-07-22
Basic data Employees n. a.
    * Document for �About Section�: Quantro Therapeutics GmbH. (7/21/20). "Press Release: Quantro Therapeutics Launched with Breakthrough Oncology Drug Discovery Platform". Vienna.
Record changed: 2020-08-04


Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Quantro Therapeutics GmbH

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture [iito] No Content Marketing 650x80px

» top